Question

A 58-year-old with HFrEF (EF 30%) is not on an SGLT2 inhibitor. BP 110/68 mm Hg, creatinine 1.3 mg/dL (eGFR 65). Which addition improves mortality and HF hospitalizations?

Accepted Answer

SGLT2 inhibitor (e.g., dapagliflozin)

Answer

Ivabradine first

Answer

Hydralazine alone

Answer

Nondihydropyridine CCB

Answer

Increase loop diuretic as monotherapy

Practice question

A 58-year-old with HFrEF (EF 30%) is not on an SGLT2 inhibitor. BP 110/68 mm Hg, creatinine 1.3 mg/dL (eGFR 65). Which addition improves mortality and HF hospitalizations?